Cargando…
Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine
Free fatty acid receptor-1 (FFAR1) is one of the possible therapeutic targets in the search for new hepatoprotective drugs. FFAR1 agonists were found to have hypolipidemic, antifibrotic, anti-inflammatory, antiproliferative and antioxidant effects in addition to hypoglycemic action. In this work, we...
Autores principales: | Pon`kina, Darya, Kuranov, Sergey, Khvostov, Mikhail, Zhukova, Nataliya, Meshkova, Yulia, Marenina, Mariya, Luzina, Olga, Tolstikova, Tatyana, Salakhutdinov, Nariman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823450/ https://www.ncbi.nlm.nih.gov/pubmed/36615590 http://dx.doi.org/10.3390/molecules28010396 |
Ejemplares similares
-
Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies
por: Pon’kina, Darya A., et al.
Publicado: (2023) -
Synthesis and Evaluation of Hypoglycemic Activity of Structural Isomers of ((Benzyloxy)phenyl)propanoic Acid Bearing an Aminobornyl Moiety
por: Kuranov, Sergey O., et al.
Publicado: (2023) -
9-N-n-alkyl Berberine Derivatives: Hypoglycemic Activity Evaluation
por: Khvostov, Mikhail V., et al.
Publicado: (2022) -
Bornyl Derivatives of p-(Benzyloxy)Phenylpropionic Acid: In Vivo Evaluation of Antidiabetic Activity
por: Kuranov, Sergey, et al.
Publicado: (2020) -
The Study of Hypoglycemic Activity of 7-Terpenylcoumarins
por: Kuranov, Sergey, et al.
Publicado: (2022)